Jennison Associates
MYOK

Jennison Associates’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Jennison Associates’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-113,654
Closed -$11M – 713
2020
Q2 		$11M Buy
+113,654
New +$9.48M 0.01% 363

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jennison Associates's MYOK Position: Q3 2020 in Review

Jennison Associates sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 113,654 shares — an estimated $11M sold.

Jennison Associates first reported a position in MYOK in Q2 2020 and held it in 1 quarter. The position peaked at $11M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Jennison Associates reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Jennison Associates sold 113,654 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $11M.
  • Jennison Associates first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Jennison Associates's MyoKardia, Inc. Common Stock position peaked at $11M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Jennison Associates's 13F filing for Q3 2020, filed 4 Nov 2020.